Cellot, G., & Cherubini, E. (2014). GABAergic signaling as therapeutic target for autism spectrum disorders. Frontiers in Pediatrics, 70(2) 1-11. doi: 10.3389/fped.2014.00070.
Frye, R.E., Rossignol, D., Casanova, M.F., Brown, G.L., Martin, V., Edelson, S., Coben, R., Lewine, J., Slattery, J.C., Lau, C., Hardy, P., Hossein Fatemi, P., Folsom, T.D., MacFabe, D., & Adams, J.B. (2013). A review of traditional and novel treatments for seizures in autism spectrum disorder: Findings from a systematic review and expert panel. Frontiers in Public Health, 1(31), 1-26. http://dx.doi.org/10.3389/fpubh.2013.00031.
Harden, A.Y., Jou, R.J., & Handed, B.I. (2004). A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 14(3), 426-432. doi: 10.1089/1044546042389082.
Levy, S.E., Mandell, D.S., & Schultz, R. (2009). Autism. Lancet, 374, 1627-3810. http://dx.doi.org/10.1016/S0140-6736(16)30530-X.
Marrosu, F., Marrosu, G., & Rachel, M.G.E.A. (1987). Paradoxical reactions elicited by diazepam in children with classic autism. Functional Neurology, 2(3), 355-361.
Mori, T., Mori, K., Fujii, E., Toda, Y., Miyazaki, M., Harada, M., Hashimoto, T., & Kagami, S. (2012). Evaluation of the GABAergic nervous system in autistic brain: (123)I-iomazenil SPECT study. Brain Development, 34(8), 648-654. http://dx.doi.org/10.3389/fpsyt.2015.00084.
National Autism Center (2015). Findings and conclusions: National standards project, phase 2. Randolph, MA: National Autism Center. Retrieved 26 September 2016 from http://www.nationalautismcenter.org/national-standards-project/results-reports/.
Prior, M., & Roberts, J. (2012). Early intervention for children with autism spectrum disorders: Guidelines for good practice. Canberra: Australian Government Department of Social Services. Retrieved 23 June 2016 from https://www.dss.gov.au/our-responsibilities/disability-and-carers/program-services/for-people-with-disability/early-intervention-for-children-with-autism-spectrum-disorders-guidelines-for-good-practice-2012.
Prior, M., Roberts, J.M., Rodger, S., Williams, K., & Sutherland, R. (2011). A review of the research to identify the most effective models of practice in early intervention for children with autism spectrum disorders. Canberra: Australian Government Department of Families, Housing, Community Services and Indigenous Affairs. Retrieved 26 September 2016 from https://www.dss.gov.au/sites/default/files/documents/10_2014/review_of_the_research_report_2011_0.pdf.
Roth, R.J., Cooper, J.R., & Bloom, F.E. (2003). The biochemical basis of neuropharmacology. Oxford: Oxford University Press.
Weitlauf, A.S., McPheeters, M.L., Peters, B., Sathe, N., Travis, R., Aiello, R., Williamson, E., Veenstra-VanderWeele, J., Krishnaswami, S., Jerome, R., & Warren, Z. (2014). Therapies for children with autism spectrum disorder: Behavioral interventions update. Comparative Effectiveness Review no. 137 [AHRQ Publication No. 14-EHC036-EF]. Rockville, MD: Agency for Healthcare Research and Quality. Retrieved 25 July 2016 from http://www.ncbi.nlm.nih.gov/books/NBK241444/.
Wong, C., Odom, S.L., Hume, K., Cox, A.W., Fettig, A., Kucharczyk, S., Brock, M.E., Plavnick, J.B., Fleury, V.P., & Schultz, T.R. (2014). Evidence-based practices for children, youth, and young adults with autism spectrum disorder. Chapel Hill, NC: University of North Carolina, Frank Porter Graham Child Development Institute, Autism Evidence-Based Practice Review Group. Retrieved 25 July 2016 from http://fpg.unc.edu/sites/fpg.unc.edu/files/resources/reports-and-policy-briefs/2014-EBP-Report.pdf.